MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05
Published February 8, 2017 · Recall initiated: December 16, 2016
Summary
FDA records drug Class II recall D-0456-2017, published February 8, 2017 and initiated December 16, 2016. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 47, 020 vials; Lot: Lot 6007327, exp. 01-2017; Lot 6007329, exp. 01-2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if MIDAZOLAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIDAZOLAM
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0363323411183
- Lot
- Lot 6007327, exp. 01-2017; Lot 6007329, exp. 01-2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b)February 8, 2017
- FDANystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDCFebruary 8, 2017
- FDAEndure 400 Scrub-Stat (chlorhexidine gluconate) Foam Forming Solution, 4%, packaged in plastic (HDPE) bottles,February 8, 2017
- FDAHydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/325 mg per 15 mL C-II, a) 4 fl.oz .(120 mL), 12February 8, 2017
- FDAFinasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc.February 8, 2017
- FDAMIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APPDecember 17, 2014
Questions about this recall
Was MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05 recalled?
Yes. FDA published recall D-0456-2017 on February 8, 2017. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIDAZOLAM. UPC: 0363323411183.